Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genentech licenses TAP technology for use with therapeutic antibodies

Aug. 1, 2005

Cellzome and Novartis expand pathway research collaboration

July 29, 2005

Evotec and Almirall sign library synthesis agreement

July 25, 2005

Vical begins phase I study of gene-based IL-2 with electroporation

July 21, 2005

Novel adenosine A3 receptor antagonists reported

July 19, 2005

Three-year extension to collaboration between Structural GenomiX and Lilly

July 18, 2005

Pharmos initiates clinical program for NanoEmulsion technology

July 8, 2005

Intranasal Technology and Aegis expand collaboration

June 23, 2005

Seattle Genetics licenses ADC technology to PSMA Development Company

June 22, 2005

Morphochem provides novel lead compounds for Novartis

June 22, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...